Effect of counterions on the properties of amorphous atorvastatin salts

European Journal of Pharmaceutical Sciences

Volumn 44, Issue 4, 2011, Pages 462-470

  Sonje, Vishal M ^a   Kumar, Lokesh ^a   Puri, Vibha ^a   Kohli, Gunjan ^a   Kaushal, Aditya M ^b   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Amorphous; Atorvastatin; Counterion; Glass transition; Salts

Indexed keywords

ATORVASTATIN; CALCIUM ION; COUNTERION; MAGNESIUM ION; SODIUM ION;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DENSITY FUNCTIONAL THEORY; DRUG STABILITY; ENTHALPY; GLASS TRANSITION TEMPERATURE; HEATING; PRIORITY JOURNAL; SPRAY DRYING; VITRIFICATION;

CALCIUM; CALORIMETRY, DIFFERENTIAL SCANNING; CATIONS; CRYSTALLIZATION; DRUG STABILITY; HEPTANOIC ACIDS; MAGNESIUM; MICROSCOPY, POLARIZATION; PHASE TRANSITION; POWDER DIFFRACTION; PYRROLES; SALTS; SODIUM; SOLUBILITY; THERMODYNAMICS; TRANSITION TEMPERATURE; VITRIFICATION; WATER; X-RAY DIFFRACTION;

EID: 80455122807     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.08.023     Document Type: Article

References (31)

1. Angell, C.A.; 1985. Relaxation in complex systems. In: Ngai, K.; Wright, G.B. (Eds.), National Technical Information Service. US Department of Commerce, Springfield, VA, p. 3.
2. C.A. Angell Relaxation in liquids, polymers and plastic crystals - strong/fragile patterns and problems J. Non-Cryst. Solids 1991 131 133 (13-31)
3. C.A. Angell, J.M. Sare, and E.J. Sare Glass transition temperatures for simple molecular liquids and their binary solutions J. Phys. Chem. 82 1978 2622 2629
4. S.M. Berge, L.D. Bighley, and D.C. Monkhouse Pharmaceutical salts J. Pharm. Sci. 66 1977 1 19
5. R. Bohmer, and C.A. Angell Local and global relaxations in glass-forming materials R. Richert, A. Blumen, Disorder Effects on Relaxational Processes 1994 Springer-Verlag Berlin, Heidelberg (11-54)
6. R. Bohmer, K. Ngai, C.A. Angell, and D. Plazek Nonexponential relaxations in strong and fragile glass formers J. Chem. Phys. 99 1993 4201 4209
7. Briggs, C.A.; Jennings, R.A.; Wade, R.; Harasawa, K.; Ichikawa, S.; Minohara, K.; Nakagawa, S. Crystalline [R-(R,R)]-2-(d-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl] -1H-pyrrole-1-heptanoic acid hemicalcium salt. US5969156, 1999.
8. U. Christians, W. Jacobsen, and L.C. Floren Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl Coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol. Ther. 80 1998 1 34 (Pubitemid 28498199)
9. K.J. Crowley, and G. Zografi The use of thermal methods for predicting glass-former fragility Thermochim. Acta 380 2001 79 93 (Pubitemid 33100002)
10. A. Eisenberg, and M.C. Shen Glass transitions in polymers Prog. Solid State Chem. 3 1966 407 481
11. P. Guerrieri, A.C.F. Rumondor, T. Li, and L.S. Taylor Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts AAPS Pharm. Sci. Tech. 11 2010 1212 1222
12. P. Gupta, G. Chawla, and A.K. Bansal Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility Mol. Pharm. 1 2004 406 413
13. S.A. Kaplan Biopharmaceutical considerations in drug formulation design and evaluation Drug Metab. Rev. 1 1972 15 34
14. A.M. Kaushal, and A.K. Bansal Thermodynamic behavior of glass state of structurally related compounds Eur. J. Pharm. Sci. 69 2008 1067 1076
15. A.M. Kaushal, P. Gupta, and A.K. Bansal Amorphous drug delivery systems: molecular aspects, design, and performance Crit. Rev. Ther. Drug Carrier Syst. 21 2004 133 193 (Pubitemid 41647581)
16. Kroselj, V.; Smrkolj, M.; Oslonik, R.; Tihi, J.; Zupet, R.; Stimac, A. Polymorphs of atorvastatin salts. WO2007/118873, 2007.
17. Leonard, J.A.; Miller, J.M. Novel forms of [R-(R,R)]-2-(4-fluorophenyl)- β,β-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl] -1H-pyrrole-1-heptanoic acid magnesium. WO2007/057755 A1, 2007.
18. C.A. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235 249 (Pubitemid 32239479)
19. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25 (Pubitemid 27046991)
20. J.C. Mauro Impact of fragility on enthalpy relaxation in glass Phys. Rev. E78 2008 021502
21. C.T. Moynihan, A.J. Easteal, J. Wilder, and J. Tucker Dependence of the glass transition temperature on heating and cooling rate J. Phys. Chem. 78 1974 2673 2677
22. E.R. Oberholtzer, and G.S. Brenner Cefoxitin sodium: solution and solid state chemical stability J. Pharm. Sci. 68 1979 863 866 (Pubitemid 9224258)
23. R.G. Parr, L. Von Szentpaly, and S.B. Liu Electrophilicity index J. Am. Chem. Soc. 121 1999 1922 1924
24. M.J. Pikal, A.L. Lukes, and J.E. Lang Thermal decomposition of amorphous β-lactam antibacterials J. Pharm. Sci. 66 1977 1312 1316 (Pubitemid 8163987)
25. J.J. Ramos, R. Taveira-Marques, and H.P. Diogo Estimation of the fragility index of indomethacin by DSC using the heating and cooling rate dependency of the glass transition J. Pharm. Sci. 93 2004 1503 1507 (Pubitemid 38725022)
26. P. Tong, L.S. Taylor, and G. Zografi Influence of alkali metal counterions on the glass transition temperature of amorphous indomethacin salts Pharm. Res. 19 2002 649 654 (Pubitemid 34553673)
27. P. Tong, and G. Zografi Solid-state characteristics of amorphous sodium indomethacin relative to its free acid Pharm. Res. 16 1999 1186 1192 (Pubitemid 29393605)
28. C.S. Towler, T. Li, H. Wikstrom, D.M. Remick, M.V. Sanchez-Felix, and L.S. Taylor An investigation into the influence of counterion on the properties of some amorphous organic salts Mol. Pharm. 5 2008 946 955
29. S. Yoshioka, and Y. Aso Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals J. Pharm. Sci. 96 2007 960 981 (Pubitemid 46797468)
30. J. Zarzycki Glasses and the vitreous state 1991 Cambridge University Press Cambridge, New York
31. D. Zhou, G.G.Z. Zhang, D. Law, D.J.W. Grant, and E.A. Schmitt Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility J. Pharm. Sci. 91 2002 1863 1872 (Pubitemid 34810531)